Participated · Series A · Oct 2022

Hey Jane is a telemedicine startup that provides virtual abortion consultations and mails medication abortion drugs (mifepristone and misoprostol) to patients. Founded in 2021, the company connects patients with healthcare providers online and fulfills medication abortions via mail delivery. Since launching in the spring of last year it has served nearly 20,000 patients, its patient base grew 200% in the last year, and it has doubled the size of its clinical team. Hey Jane has expanded beyond its initial three-state footprint to operate in multiple additional states, including California, Colorado, Connecticut, Illinois, New Jersey, New Mexico, New York and Washington. Financially, the startup has raised $9.7 million to date, including a recent $6.1 million Series A. Going forward it plans to increase public awareness of medication abortion and broaden access to reproductive care via telemedicine and medication delivery. Hey Jane operates a remote-first telemedicine clinic that offers a $249 treatment including screening by a medical doctor, FDA-approved medication prescribed and shipped overnight, follow-up virtual visits, chat access to a doctor, and frequent text check-ins. The company does not yet accept insurance but offers financial assistance through nonprofit partner Reprocare, which can subsidize up to $110 of the cost so patients may pay as little as $139. Hey Jane is a seven-person team seeing 250% quarterly growth in patient volume and says its service areas now cover up to 34% of all U.S. abortions performed annually. The startup has launched across California and also operates in New York and Washington, and the team expects to be in 10 states by year-end with a goal of offering treatment in all 50 states in coming years. Hey Jane is partnering with the Advancing New Standards in Reproductive Health research group at UCSF to expand evidence supporting telemedicine abortion and is monitoring state-by-state telemedicine and abortion regulations.

Participated · Series B · Apr 2022

PhableCare is an app-based, full-stack chronic disease management platform that connects patients, doctors, pharmacists, device makers, hospitals, e-pharmacies and insurers. Its solution delivers remote consultations, decision-support for doctors, patient engagement, IoT device integration and data-driven disease management. The platform already serves 3M+ patients, 10k+ doctors and 1k+ pharmacists, making it a market leader in India’s chronic-care segment. The company plans to expand to 30M+ Indian households and 100,000+ super-specialist doctors and aims to capture 25% of the market over the next two years. PhableCare will use recent funding to strengthen its full-stack, value-driven chronic-care ecosystem, accelerate customer acquisition and brand building, build new revenue streams, and pursue strategic acquisitions. It has also allocated capital and arranged additional venture-debt to invest in other health-tech startups to expand capacity and capabilities. PhableCare operates a technology platform that creates an ecosystem of patients, doctors, hospitals, health devices, insurance and patient-care service providers to manage chronic diseases. The company provides online doctor consultations and a mobile app that lets patients order medicines, connect health IoT devices (Google Fit, Fitbit, Garmin) and manually or visually upload test results via computer vision. Its platform claims a network of 5,000+ doctors, more than 20,000 booked online consultations, and tracking of over 30 million patients' vitals. The founders say the company aims to reach 5 million patients and 35,000 doctors by the end of the year. PhableCare was founded in 2017 and is led by founders Mukesh Bansal, Sumit Sinha and Prasanth Reddy. To date the startup has raised over $13 million in funding.

Participated · Seed · Nov 2021

Ombre (formerly Thryve) is a San Francisco-based wellness company that merges science and wellness to deliver individualized self-care. Its offerings include at-home microbiome tests, probiotic subscription services, and tailored lifestyle and diet recommendations. The company recently appointed Elise Contarsy as CEO. Contarsy has prior consumer product branding and merchandising leadership at Bonnier Consumer Products, Meredith Corporation, Bed Bath & Beyond, Martha Stewart Living and Calvin Klein Home. Ombre raised $3M in a Seed round, bringing total funding to $9.5M. The team includes microbiome specialist Kimberly Griffith, Chief Product Officer Piotr Kuczynski, VP B2B Michael Preininger, and merchandise operations manager Liza Wallace. Thryve sells an at-home microbiome testing kit and a monthly subscription that delivers individualized probiotics and a Gut Wellness Score. The company’s core product combines stool-based microbiome analysis with personalized diet and lifestyle recommendations backed by thousands of studies. Samples are processed at a partner laboratory at the University of Chicago Argonne National Laboratory. Subscribers receive monthly boxes (probiotics and reports); subscriptions start at $59.95 per month. Thryve also offers an option for users to contribute anonymized data to support microbiome research and expand scientific knowledge. Company leadership has stated plans to expand Thryve’s products and services and to leverage crowdsourced data for research.

Participated · Seed · Sep 2021

Mae is a culturally competent digital health platform connecting Black expectant mothers with critical resources to drive positive pregnancy outcomes. The product pairs doula-style continuous support with health tracking tools that enable early identification of pregnancy risk factors, plus curated, culturally specific educational and lifestyle resources available on demand. Mae launched with a $1.3M pre-seed funding round led by SteelSky Ventures. Founder and CEO Maya Hardigan created Mae after 15 years in digital health product innovation, most recently at Pfizer, and collaborated with leaders of large healthcare corporations to develop the hybrid care offering. The company works in concert with healthcare payers and states and plans to become a value-based, supplemental care approach to improve care for Black pregnant women. Mae positions its model to address maternal health inequities amid policy shifts expanding postpartum Medicaid coverage and growing reimbursement consideration for doulas and related services.

Participated · Seed · May 2021

Flex positions itself as a private bank for high-net-worth and middle-market business owners, providing multi-currency accounts, stablecoin payment systems and wallets, institutional USD accounts, private credit, business cards across entities, and an AI finance agent called Beacon. The company has launched Flex Global, a stablecoin-powered banking service available in more than 100 countries, with multi-currency accounts in 76 countries supporting 32 currencies. Flex reports strong growth metrics: annualised total payment volume exceeding $10 billion, annualised revenue now in nine figures after tripling since December, and customers using an average of four or more products. Its largest client categories by count are construction, wholesale, and multinational businesses, and it targets an estimated 350,000 high-net-worth business owners in the U.S. and about 3 million worldwide. Flex plans to expand into business finance, personal finance, payments, private credit, and ERP, and to roughly double headcount from ~110 to over 200 within the year.